References
- Palop JJ, Chin J, Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature 2006;443:768–73.
- Lane RM, Potkin SG, Enz A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol. 2006;9:101–24.
- Bailey JA, Lahiri DK. Chromatographic separation of reaction products from the choline acetyltransferase and carnitine acetyltransferase assay: differential ChAT and CrAT activity in brain extracts from Alzheimer's disease versus controls. J Neurochem 2012;122:672–80.
- Schliebs R, Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm 2006;113:1625–44.
- Meng JZ, Guo LW, Cheng H, Correlation between cognitive function and the association fibers in patients with Alzheimer's disease using diffusion tensor imaging. J Clin Neurosci 2012;19:1659–63.
- Evans JG, Wilcock G, Birks J. Evidence-based pharmacotherapy of Alzheimer's disease. Int J Neuropsychopharmacology. 2004;7:351–69.
- Linseman DA, Loucks FA. Diverse roles of Rho family GTPases in neuronal development, survival, and death. Front Biosci 2008;13:657–76.
- Hashimoto R, Nakamura Y, Kosako H, Distribution of Rho-kinase in the bovine brain. Biochem Biophys Res Commun 1999;263:575–9.
- Salminen A, Suuronen T, Kaarniranta K. ROCK, PAK, and toll of synapses in Alzheimer's disease. Biochem Biophys Res Commun 2008;371:587–90.
- Calabrese B, Wilson MS, Halpain S. Development and regulation of dendritic spine synapses. Physiology 2006;21:38–47.
- Petratos S, Li QX, George AJ, The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 2008;131:90–108.
- Gu H, Yu SP, Gutekunst CA, Inhibition of the Rho signaling pathway improves neurite outgrowth and neuronal differentiation of mouse neural stem cells. Int J Physiol Pathophysiol Pharmacol 2013;5:11–20.
- Liang Y, Liu Z, Shuai X, Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration. Biochem Biophys Res Commun 2012;421:690–5.
- Neu M, Germershaus O, Behe M, Kissel T. Bioreversibly crosslinked polyplexes of PEI and high molecular weight PEG show extended circulation times in vivo. J Controlled Release 2007;124:69–80.
- Liu Y, Liu Z, Wang Y, Investigation of the performance of PEG-PEI/ROCK-II-siRNA complexes for Alzheimer's disease in vitro. Brain Res 2013;1490:43–51.
- Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984;11:47–60.
- Hemming ML, Patterson M, Reske-Nielsen C, Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease. PLoS Med 2007;4:e262.
- Dodart JC, Marr RA, Koistinaho M, Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 2005;102:1211–6.
- Singer O, Marr RA, Rockenstein E, Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci 2005;8:1343–9.
- Tuszynski MH. Nerve growth factor gene therapy in Alzheimer disease. Alzheimer Dis Assoc Disord 2007;21:179–89.
- Lepley D, Paik JH, Hla T, Ferrer F. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Cancer Res 2005;65:3788–95.
- Shimokawa H, Rashid M. Development of Rho-kinase inhibitors for cardiovascular medicine. Trends Pharmacol Sci 2007;28:296–302.
- Hou Y, Zhou L, Yang QD, Changes in hippocampal synapses and learning-memory abilities in a streptozotocin-treated rat model and intervention by using fasudil hydrochloride. Neuroscience 2012;200:120–9.
- Rivera EJ, Goldin A, Fulmer N, Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis 2005;8:247–68.
- Matsui N, Takahashi K, Takeichi M, Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice. Brain Res 2009;1305: 108–17.
- Strong R, Reddy V, Morley JE. Cholinergic deficits in the septal-hippocampal pathway of the SAM-P/8 senescence accelerated mouse. Brain Res 2003;966:150–6.
- Flood JF, Farr SA, Kaiser FE, Morley JE. Age-related impairment in learning but not memory in SAMP8 female mice. Pharmacol Biochem Behav 1995;50:661–4.